Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, $0.00001 par value
-
Shares outstanding
-
19.1M
-
Number of holders
-
29
-
Total 13F shares, excl. options
-
4.25M
-
Shares change
-
+1.99M
-
Total reported value, excl. options
-
$21.8M
-
Value change
-
+$10.2M
-
Put/Call ratio
-
0.06
-
Number of buys
-
18
-
Number of sells
-
-7
-
Price
-
$5.14
Significant Holders of enVVeno Medical Corp - Common Stock, $0.00001 par value (NVNO) as of Q4 2023
36 filings reported holding NVNO - enVVeno Medical Corp - Common Stock, $0.00001 par value as of Q4 2023.
enVVeno Medical Corp - Common Stock, $0.00001 par value (NVNO) has 29 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.25M shares
of 19.1M outstanding shares and own 22.19% of the company stock.
Largest 10 shareholders include Nantahala Capital Management, LLC (706K shares), PERCEPTIVE ADVISORS LLC (623K shares), KINGDON CAPITAL MANAGEMENT, L.L.C. (619K shares), ARMISTICE CAPITAL, LLC (436K shares), Altium Capital Management LP (344K shares), VANGUARD GROUP INC (336K shares), Rosalind Advisors, Inc. (312K shares), UBS OCONNOR LLC (236K shares), Velan Capital Investment Management LP (172K shares), and GEODE CAPITAL MANAGEMENT, LLC (122K shares).
This table shows the top 29 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.